Official Title
A PHASE 1/2 RANDOMIZED, DOUBLE-BLINDED STUDY TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF MODIFIED RNA VACCINE CANDIDATES AGAINST INFLUENZA AND COVID-19 IN HEALTHY INDIVIDUALS
Brief Summary

The purpose of this study is to learn about how the flu and COVID vaccines act when givenalone or when mixed together.This study is seeking healthy participants aged 18 or older. All participants in thisstudy will receive only 1 shot to their arm, either a flu or COVID vaccine, alone ormixed. Participants will take part in this study for about 6 months, and participantswill need to visit the clinical study site at least 4 times.

Detailed Description

Not Provided

Recruiting
Influenza
COVID-19 (Coronavirus Disease 2019)

Biological: Investigational Influenza Vaccine

Investigational Influenza Vaccine

Biological: Investigational COVID-19 Vaccine

Investigational COVID-19 Vaccine

Combination Product: Investigational Influenza and COVID-19 Combination Vaccine

Investigational Combined Influenza and COVID-19 Vaccine

Biological: Licensed Influenza Vaccine 1

Licensed Influenza Vaccine 1

Biological: Licensed Influenza Vaccine 2

Licensed Influenza Vaccine 2

Biological: Licensed Influenza Vaccine 3

Licensed Influenza Vaccine 3

Biological: Licensed COVID-19 Vaccine

Pfizer-BioNTech COVID-19 Vaccine

Eligibility Criteria

Inclusion criteria:

- Participants 18 years of age or older

- Healthy participants who are determined by medical history, physical examination (if
clinically required), and clinical judgement of the investigator to be eligible for
inclusion in the study

Exclusion criteria:

- Vaccination with any investigational or licensed influenza vaccine within 150 days
of enrollment

- Vaccination with any investigational or licensed COVID 19 vaccine within 150 days of
enrollment.

- Receipt of antiviral therapies for influenza (eg, Tamiflu) within 180 days prior to
Day 1.

Refer to the study contact for further eligibility details

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Anaheim Clinical Trials, LLC
Anaheim, California, United States

Orange County Research Center
Lake Forest, California, United States

Artemis Institute for Clinical Research
Riverside, California, United States

Artemis Institute for Clinical Research
San Diego, California, United States

Diablo Clinical Research, Inc.
Walnut Creek, California, United States

Clinical Research Consulting
Milford, Connecticut, United States

Alliance for Multispecialty Research, LLC
Coral Gables, Florida, United States

Indago Research & Health Center, Inc
Hialeah, Florida, United States

Palm Springs Community Health Center
Miami Lakes, Florida, United States

Miami Dade Medical Research Institute, LLC
Miami, Florida, United States

Clinical Research Atlanta
Stockbridge, Georgia, United States

East-West Medical Research Institute
Honolulu, Hawaii, United States

Clinical Research Professionals
Chesterfield, Missouri, United States

Las Vegas Clinical Trials
North Las Vegas, Nevada, United States

Trial Management Associates - Wilmington - Floral Parkway
Wilmington, North Carolina, United States

Centricity Research Columbus Ohio Multispecialty
Columbus, Ohio, United States

DM Clinical Research - Philadelphia
Philadelphia, Pennsylvania, United States

Coastal Carolina Research Center
North Charleston, South Carolina, United States

Clinical Research Associates Inc
Nashville, Tennessee, United States

Headlands Horizons, LLC dba Headlands Research-Brownsville
Brownsville, Texas, United States

DM Clinical Research- Cyfair
Houston, Texas, United States

SMS Clinical Research
Mesquite, Texas, United States

Dynamed Clinical Research, LP d/b/a DM Clinical Research
Tomball, Texas, United States

J. Lewis Research, Inc. / Foothill Family Clinic
Salt Lake City, Utah, United States

J. Lewis Research, Inc. / Foothill Family Clinic South
Salt Lake City, Utah, United States

Charlottesville Medical Research
Charlottesville, Virginia, United States

Contacts

Pfizer CT.gov Call Center
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com

Pfizer CT.gov Call Center, Study Director
Pfizer

NCT Number
MeSH Terms
COVID-19
Influenza, Human
Vaccines